Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis

Abstract Introduction In this retrospective analysis, we evaluate the effectiveness of the potassium (K+) binder sodium zirconium cyclosilicate (SZC) in maintaining normokalemia and facilitating the initiation, optimization, and maintenance of renin–angiotensin–aldosterone system inhibitors (RAASi)...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Rhys Williams, William Ford, Alexander James, Kerys Thomas, Aaron Wong
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2024-11-01
Sarja:	Cardiology and Therapy
Aiheet:	Heart failure Hyperkalemia Renin–angiotensin–aldosterone system inhibitor Sodium zirconium cyclosilicate
Linkit:	https://doi.org/10.1007/s40119-024-00388-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!